Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?
- PMID: 12882349
- DOI: 10.1046/j.1474-9728.2002.00001.x
Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?
Abstract
Levels of iron are increased in the brains of Parkinson's disease (PD) patients compared to age-matched controls. This has been postulated to contribute to progression of the disease via several mechanisms including exacerbation of oxidative stress, initiation of inflammatory responses and triggering of Lewy body formation. In this minireview, we examine the putative role of iron in PD and its pharmacological chelation as a prospective therapeutic for the disease.
Similar articles
-
Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.J Mol Neurosci. 2004;24(3):401-16. doi: 10.1385/JMN:24:3:401. J Mol Neurosci. 2004. PMID: 15655262
-
Ceruloplasmin activity and iron chelation treatment of patients with Parkinson's disease.BMC Neurol. 2015 May 6;15:74. doi: 10.1186/s12883-015-0331-3. BMC Neurol. 2015. PMID: 25943368 Free PMC article. Clinical Trial.
-
Parkinson's disease and iron.J Neural Transm (Vienna). 2020 Feb;127(2):181-187. doi: 10.1007/s00702-020-02149-3. Epub 2020 Feb 5. J Neural Transm (Vienna). 2020. PMID: 32025811 Review.
-
TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.Brain Res. 2000 Sep 22;877(2):379-81. doi: 10.1016/s0006-8993(00)02702-5. Brain Res. 2000. PMID: 10986355
-
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.Free Radic Biol Med. 2013 Sep;62:52-64. doi: 10.1016/j.freeradbiomed.2013.01.017. Epub 2013 Jan 30. Free Radic Biol Med. 2013. PMID: 23376471 Review.
Cited by
-
Design and synthesis of N-hydroxyalkyl substituted deferiprone: a kind of iron chelating agents for Parkinson's disease chelation therapy strategy.J Biol Inorg Chem. 2021 Jun;26(4):467-478. doi: 10.1007/s00775-021-01863-x. Epub 2021 May 8. J Biol Inorg Chem. 2021. PMID: 33963933
-
Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.Int J Mol Sci. 2020 Nov 20;21(22):8765. doi: 10.3390/ijms21228765. Int J Mol Sci. 2020. PMID: 33233496 Free PMC article. Review.
-
Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson's disease through AKT/mTOR pathway.Aging (Albany NY). 2020 May 18;12(10):9515-9533. doi: 10.18632/aging.103225. Epub 2020 May 18. Aging (Albany NY). 2020. PMID: 32424108 Free PMC article.
-
A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases.Mol Divers. 2019 May;23(2):509-526. doi: 10.1007/s11030-018-9878-4. Epub 2018 Oct 6. Mol Divers. 2019. PMID: 30293116 Review.
-
Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease.J Nutr. 2017 Oct;147(10):1926-1931. doi: 10.3945/jn.117.255034. Epub 2017 Aug 23. J Nutr. 2017. PMID: 28835392 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical